Category: Alzheimer’s disease

Aducanumab controversies

Yesterday I participated in a panel discussion regarding recommendations for use of aducanumab, now called by the proprietary name Aduhelm, in the treatment of Alzheimer’s disease. The conference, Dialogue: Current Perspectives on Aducanumab, was sponsored...

Sensory triggers of memory

Marcel Proust famously wrote in his semi-autobiographical novel Remembrance of Things Past published in 1913 how the smell and taste of a tea-soaked madeleine cake evoked the childhood memory of breakfast with his Aunt Léonie. The...

FDA approves aducanumab

Today the FDA approved the use of Biogen’s anti-amyloid monoclonal antibody aducanumab for treating early-stage Alzheimer’s disease.  I have mixed feelings about this approval. As someone living with early-stage Alzheimer’s who participated in the aducanumab...

Beacon Rock Revisited

As those of you who have read Tattoo will know, Beacon Rock is a special place for me.  It is a basalt monolith towering 848 ft over the north bank of the Columbia River about 35 miles...

Shipping delays

The good news is Tattoo was released on schedule in the UK on May 6 and has been well received. This photo of the Tattoo display in a window of the Cambridge University Press...

Tattoo release week

It’s hard for me to believe it, but Tattoo will be released this Thursday, May 6, both in the US and UK. This journey began over two years ago when I published an opinion paper in JAMA...